258 related articles for article (PubMed ID: 22696263)
1. Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment.
Lee SJ; Huh MS; Lee SY; Min S; Lee S; Koo H; Chu JU; Lee KE; Jeon H; Choi Y; Choi K; Byun Y; Jeong SY; Park K; Kim K; Kwon IC
Angew Chem Int Ed Engl; 2012 Jul; 51(29):7203-7. PubMed ID: 22696263
[TBL] [Abstract][Full Text] [Related]
2. Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance.
Yhee JY; Song S; Lee SJ; Park SG; Kim KS; Kim MG; Son S; Koo H; Kwon IC; Jeong JH; Jeong SY; Kim SH; Kim K
J Control Release; 2015 Jan; 198():1-9. PubMed ID: 25481438
[TBL] [Abstract][Full Text] [Related]
3. Self-crosslinked human serum albumin nanocarriers for systemic delivery of polymerized siRNA to tumors.
Son S; Song S; Lee SJ; Min S; Kim SA; Yhee JY; Huh MS; Chan Kwon I; Jeong SY; Byun Y; Kim SH; Kim K
Biomaterials; 2013 Dec; 34(37):9475-85. PubMed ID: 24050874
[TBL] [Abstract][Full Text] [Related]
4. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
5. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
[TBL] [Abstract][Full Text] [Related]
6. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.
Huh MS; Lee SY; Park S; Lee S; Chung H; Lee S; Choi Y; Oh YK; Park JH; Jeong SY; Choi K; Kim K; Kwon IC
J Control Release; 2010 Jun; 144(2):134-43. PubMed ID: 20184928
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeting transferrin nanoparticles for systemic polymerized siRNA delivery in tumor-bearing mice.
Yhee JY; Lee SJ; Lee S; Song S; Min HS; Kang SW; Son S; Jeong SY; Kwon IC; Kim SH; Kim K
Bioconjug Chem; 2013 Nov; 24(11):1850-60. PubMed ID: 24107100
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo.
Lee SJ; Yook S; Yhee JY; Yoon HY; Kim MG; Ku SH; Kim SH; Park JH; Jeong JH; Kwon IC; Lee S; Lee H; Kim K
J Control Release; 2015 Dec; 220(Pt B):631-41. PubMed ID: 26307351
[TBL] [Abstract][Full Text] [Related]
9. TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis.
Lee SJ; Lee A; Hwang SR; Park JS; Jang J; Huh MS; Jo DG; Yoon SY; Byun Y; Kim SH; Kwon IC; Youn I; Kim K
Mol Ther; 2014 Feb; 22(2):397-408. PubMed ID: 24145554
[TBL] [Abstract][Full Text] [Related]
10. Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.
Han L; Tang C; Yin C
Biomaterials; 2014 May; 35(15):4589-600. PubMed ID: 24613049
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery.
Lee DW; Yun KS; Ban HS; Choe W; Lee SK; Lee KY
J Control Release; 2009 Oct; 139(2):146-52. PubMed ID: 19567259
[TBL] [Abstract][Full Text] [Related]
12. Biocompatible gelatin nanoparticles for tumor-targeted delivery of polymerized siRNA in tumor-bearing mice.
Lee SJ; Yhee JY; Kim SH; Kwon IC; Kim K
J Control Release; 2013 Nov; 172(1):358-366. PubMed ID: 24036198
[TBL] [Abstract][Full Text] [Related]
13. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
14. Multimerized siRNA cross-linked by gold nanoparticles.
Kong WH; Bae KH; Hong CA; Lee Y; Hahn SK; Park TG
Bioconjug Chem; 2011 Oct; 22(10):1962-9. PubMed ID: 21899352
[TBL] [Abstract][Full Text] [Related]
15. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles.
Pittella F; Miyata K; Maeda Y; Suma T; Watanabe S; Chen Q; Christie RJ; Osada K; Nishiyama N; Kataoka K
J Control Release; 2012 Aug; 161(3):868-74. PubMed ID: 22580114
[TBL] [Abstract][Full Text] [Related]
17. Chitosan/VEGF-sIRNA nanoparticle for gene silencing.
Yang Y; Liu X; Zhang D; Yu W; Lv G; Xie H; Zheng J; Ma X
J Control Release; 2011 Nov; 152 Suppl 1():e160-1. PubMed ID: 22195822
[No Abstract] [Full Text] [Related]
18. Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
Hatakeyama H; Wu SY; Mangala LS; Lopez-Berestein G; Sood AK
Methods Mol Biol; 2016; 1402():189-197. PubMed ID: 26721492
[TBL] [Abstract][Full Text] [Related]
19. Dual-targeting and pH/redox-responsive multi-layered nanocomplexes for smart co-delivery of doxorubicin and siRNA.
Han L; Tang C; Yin C
Biomaterials; 2015 Aug; 60():42-52. PubMed ID: 25982552
[TBL] [Abstract][Full Text] [Related]
20. Rolling circle transcription-based polymeric siRNA nanoparticles for tumor-targeted delivery.
Lee JH; Ku SH; Kim MJ; Lee SJ; Kim HC; Kim K; Kim SH; Kwon IC
J Control Release; 2017 Oct; 263():29-38. PubMed ID: 28373128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
